There are currently 13 active clinical trials seeking participants for Carcinoma, Hepatocellular research studies. The states with the highest number of trials for Autism participants are California, New York, Texas and Florida.
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
Recruiting
The investigators hypothesize that the addition of Tislelizumab after definitive local therapy for locally advanced inoperable Hepatocellular carcinoma (HCC) will synergize with local therapy as well as treat micro metastatic disease and improve one year progression-free survival rates for participants and optimize local control.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/10/2023
Locations: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey +1 locations
Conditions: Carcinoma, Hepatocellular, Liver Cell Carcinoma